Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$221.31 - $316.61 $1.14 Million - $1.63 Million
-5,137 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$189.18 - $286.44 $40,673 - $61,584
215 Added 4.37%
5,137 $1.47 Million
Q2 2020

Aug 11, 2020

BUY
$123.9 - $195.41 $114,607 - $180,754
925 Added 23.14%
4,922 $927,000
Q1 2020

May 14, 2020

BUY
$121.84 - $173.19 $19,250 - $27,364
158 Added 4.12%
3,997 $492,000
Q2 2019

Aug 13, 2019

BUY
$113.99 - $146.86 $39,782 - $51,254
349 Added 10.0%
3,839 $476,000
Q4 2018

Feb 11, 2019

BUY
$107.01 - $175.15 $373,464 - $611,273
3,490 New
3,490 $490,000

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.7B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.